2-Allylamino-4-cyclohexylamino-7-methylthieno[3,2-d] pyrimidine hydrochloride | 221042-45-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并嘧啶酮衍生物
• 英文名称: 2-Allylamino-4-cyclohexylamino-7-methylthieno[3,2-d] pyrimidine hydrochloride
• 英文别名: 2-Allylamino-4-cyclohexylamino-7-methylthieno[3,2-d]pyrimidine hydrochloride；4-N-cyclohexyl-7-methyl-2-N-prop-2-enylthieno[3,2-d]pyrimidine-2,4-diamine;hydrochloride
• CAS: 221042-45-1
• 化学式: C₁₆H₂₂N₄S*ClH
• 分子量: 338.904
• InChiKey: YJWCWYNCXPPVBG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.76
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  78.1
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  丙烯胺 、 2-Chloro-4-cyclohexylamino-7-methylthieno[3,2-d] pyrimidine 在 乙酸乙酯 、 水 、 Sodium sulfate-III 、 silica gel 、 ethyl acetate n-hexane 、 ethyl acetate hydrochloride 作用下， 以 水 为溶剂， 反应 24.0h， 以to give 200 mg (yield: 66.7%) of the title compound的产率得到2-Allylamino-4-cyclohexylamino-7-methylthieno[3,2-d] pyrimidine hydrochloride
  参考文献：
  名称：

  PYRIMIDINE NUCLEUS-CONTAINING COMPOUND AND A MEDICAMENT CONTAINING THE SAME FOR A BLOOD OXYGEN PARTIAL PRESSURE AMELIORATION, AND A METHOD FOR PREPARING THE SAME

  摘要：

  式(I)所表示的含有嘧啶核的化合物：其中，环A表示式(a)的环：其中R1是硝基基团、氨基基团、取代氨基基团或卤素原子，或者表示式(b)的环：其中R1'是如烷基或烯基等基团；R2到R5独立地表示如烷基或烯基等基团；但至少有一个R2到R5是烯基基团，或其酸加成盐。

  公开号：

  US20010006969A1

文献信息

• Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
  申请人：Fujirebio Inc.

  公开号：US06339089B2

  公开（公告）日：2002-01-15

  A pyrimidine nucleus-containing compound represented by the formula (I): wherein ring A represents the ring of the formula (a): in which R1 is a nitro group, an amino group, a substituted amino group or a halogen atom, or the ring of the formula (b): in which R1′ is the group such as an alkyl group or an alkenyl group; R2 to R5 independently represent the group such as an alkyl group or an alkenyl group; with the proviso that at least one of R2 to R5 is an alkenyl group, or acid addition salts thereof.

  一种含有嘧啶核的化合物，其化学式表示为（I）：其中环A代表化学式（a）的环：其中R1是硝基基团、氨基基团、取代氨基基团或卤素原子，或者化学式（b）的环：其中R1'是诸如烷基基团或烯基基团的基团；R2至R5独立地代表诸如烷基基团或烯基基团的基团；但至少有一个R2到R5是烯基基团，或其酸加成盐。
• Fused pyrimidine derivatives and medicaments thereof for a blood oxygen partial pressure amelioration
  申请人：Fujirebio Inc.

  公开号：EP0899263A2

  公开（公告）日：1999-03-03

  A pyrimidine nucleus-containing compound represented by the formula (I): wherein ring A represents the ring of the formula (a): in which R1 is a nitro group, an amino group, a substituted amino group or a halogen atom, or the ring of the formula (b): in which R1' is the group such as an alkyl group or an alkenyl group; R2 to R5 independently represent the group such as an alkyl group or an alkenyl group; with the proviso that at least one of R2 to R5 is an alkenyl group, or acid addition salts thereof.

  由式(I)代表的含嘧啶核的化合物： 其中环 A 代表式（a）的环： 其中 R1 是硝基、氨基、取代氨基或卤素原子，或式（b）的环： 其中 R1'是烷基或烯基等基团；R2 至 R5 独立代表烷基或烯基等基团；但 R2 至 R5 中至少有一个是烯基，或其酸加成盐。
• US6339089B2
  申请人：——

  公开号：US6339089B2

  公开（公告）日：2002-01-15
• PYRIMIDINE NUCLEUS-CONTAINING COMPOUND AND A MEDICAMENT CONTAINING THE SAME FOR A BLOOD OXYGEN PARTIAL PRESSURE AMELIORATION, AND A METHOD FOR PREPARING THE SAME
  申请人：——

  公开号：US20010006969A1

  公开（公告）日：2001-07-05

  A pyrimidine nucleus-containing compound represented by the formula (I): 1 wherein ring A represents the ring of the formula (a): 2 in which R 1 is a nitro group, an amino group, a substituted amino group or a halogen atom, or the ring of the formula (b) 3 in which R 1′ is the group such as an alkyl group or an alkenyl group; R 2 to R 5 independently represent the group such as an alkyl group or an alkenyl group; with the proviso that at least one of R 2 to R 5 is an alkenyl group, or acid addition salts thereof.

  化合物的中心含有嘧啶核，其化学式表示为（I）： 其中环A代表化学式（a）的环： 其中R1是硝基、氨基、取代氨基或卤素原子，或者是化学式（b）的环： 其中R1'是诸如烷基或烯基等基团；R2到R5独立地代表诸如烷基或烯基等基团；但至少R2到R5中的一个是烯基，或其酸盐。